QuVa Pharma, Inc. is recalling 528 bags of Norepinephrine 4 mg (16 mcg/mL) added to 5% Dextrose (250 mL bags) because the product may not actually contain any of the active medication. This subpotent drug could fail to provide the necessary treatment to patients in critical hospital settings. This prescription-only medication was distributed nationwide to hospitals between August and September 2018. If you are a hospital administrator or healthcare provider, you should immediately check your inventory for the affected lot and contact the manufacturer to return any remaining supply.
Patients receiving this product may not receive the intended dose of norepinephrine, a critical medication used to increase blood pressure in emergency situations. The lack of active ingredient could lead to a failure to stabilize a patient's blood pressure, potentially resulting in life-threatening clinical consequences.
Drug recall refund and consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.